Over the past three years, the U.S. Supreme Court has issued a spate of rulings regarding the doctrine of federal pre-emption that have dramatically changed which medical product manufacturers can be held liable in tort, and for what. These decisions have been technical and seemingly inconsistent in their results, and those looking for a cohesive, disciplined or consistent doctrinal approach to pre-emption jurisprudence will ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In